Suzhou Basecare Medical Corporation Limited
Suzhou Basecare Medical Corporation Limited, an investment holding company, engages in the research, development, manufacture, and provision of genetic testing solutions for assisted reproduction and sale of genetic testing devices and instruments in the…
Medical - Devices
CN, Suzhou [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q2 | Q4 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 0.00 | 6.22 | 6.22 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | 100.00 | 4.78 | 0.00 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q2 | Q4 | Δ in % | |
|---|---|---|---|---|
| Book Value | 100.00 | 5.12 | 0.00 | |
| Cash | 100.00 | 3.46 | 0.00 | |
| Capex | -100.00 | -0.20 | 0.00 | |
| Free Cash Flow | -100.00 | -0.70 | 0.00 | |
| Revenue | 100.00 | 0.48 | 0.00 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q2 | Q4 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | 100.00 | 0.44 | 0.00 | |
| Operating Margin | -100.00 | -1.16 | 0.00 | |
| ROA | n.A. | -0.07 | n.A. | |
| ROE | n.A. | -0.10 | n.A. | |
| ROIC | n.A. | -0.09 | n.A. | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of 2170.HK is permitted for members.
5
Growth
The "Growth Entry" for the Focus of 2170.HK is permitted for members.
6
Leverage & Liquidity